Recent developments in pharmaceutical products liability law: failure to warn, the learned intermediary defense, and other issues in the new millennium.
作者信息
Garbutt Bernard J, Hofmann Melinda E
机构信息
Morgan, Lewis & Bockius L.L.P., New York, NY, USA.
出版信息
Food Drug Law J. 2003;58(2):269-86.
PMID:12866558
Abstract
摘要
相似文献
1
2
A defense of the learned intermediary doctrine.对知悉中介原则的辩护。
Food Drug Law J. 2008;63(2):421-38.
3
Legal issues concerning the promotion of pharmaceutical products on the internet to consumers.关于在互联网上向消费者推广药品的法律问题。
Food Drug Law J. 1996;51(3):355-65.
4
Medicine goes Madison Avenue: an evaluation of the effect of direct-to-consumer pharmaceutical advertising on the learned intermediary doctrine.医学走向麦迪逊大道：对直接面向消费者的药品广告对有学识的中间人原则的影响的评估。
Spec Law Dig Health Care Law. 1998 Dec(236):9-29.
5
Regulation of online pharmacy: an Australian perspective.在线药房监管：澳大利亚视角
J Law Med. 2003 Feb;10(3):339-63.
6
7
The case for preemption of prescription drug failure-to-warn claims.处方药未警示索赔的优先适用情形。
Food Drug Law J. 2007;62(2):399-422.
8
The Pharmaceutical Access and Prudent Purchasing Act of 1990: Federal law shifts the duty to warn from the physician to the pharmacist.1990年《药品获取与审慎采购法案》：联邦法律将警示义务从医生转移至药剂师。
Spec Law Dig Health Care (Mon). 1993 Dec(178):9-30.
9
Reimagining the learned intermediary rule for the new pharmaceutical marketplace.重新构想新药品市场的知悉中介规则。
Seton Hall Law Rev. 2004;35(1):193-261.
10
The federal preemption debate in pharmaceutical labeling product liability actions.药品标签产品责任诉讼中的联邦优先适用权辩论。
Tort Trial Insur Pract Law J. 2007 Fall;43(1):35-70.
Zotero 插件